10/31/2022 0 Comments Johnson photo plus![]() ![]() ![]() Provide safe and easy delivery using the new TECNIS Simplicity® system that streamlines lens delivery and protects against contamination 10.Deliver better image contrast in low light 9 TECNIS Eyhance IOLs deliver 30% improvement in image contrast compared to AcrySof IQ SN60WF at 5mm.Slightly extend the depth of focus 1 * through the unique shape of the lens.The latest innovation in the TECNIS® Family of IOLs - TECNIS Eyhance and TECNIS Eyhance Toric II IOLs – is defining the future of monofocals, with a breakthrough refractive surface designed to: “It’s the first monofocal designed to provide a slight increase in the depth of focus, 1*8, which is something I need for the patients in my practice looking for more from a monofocal.” "84% of surgeons 7 choose monofocal IOLs for their cataract patients, so it’s thrilling to see the first breakthrough in monofocal technology in decades enter the market to add to our treatment portfolio,” said Douglas Koch, M.D., Houston, TX****. Today, cataract treatments can also offer patients vision correction, reducing or eliminating the need for glasses, in addition to removing the cataract. Cataract surgery is one of the most common outpatient procedures performed today and has a success rate of approximately 98% 4. In fact, cataracts are the leading cause of preventable blindness worldwide, impacting more than 100 million eyes 3. While part of the normal aging of the eye, left untreated, cataracts cause vision to deteriorate over time. More than 90% of people develop cataracts-the clouding and yellowing of the lens in the eye-by the age of 65 2. The first implantation of TECNIS Eyhance IOL in the U.S. now have the ability to choose this next generation monofocal as the lens of choice for their patients with or without astigmatism. With this approval and subsequent commercial launch, ophthalmologists in the U.S. ![]() Food and Drug Administration (FDA) approved the TECNIS EyhanceTM and TECNIS EyhanceTM Toric II intraocular lens (IOL) for the treatment of cataract patients in the United States. SANTA ANA, CA – Febru– Johnson & Johnson Vision**, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies***, today announced that the U.S. Latest IOL in the proven TECNIS® family of IOLs, which celebrates its 20th anniversary this year First innovation in monofocal technology in 20 years is designed to slightly extend the depth of focus* ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |